|
|
||||||||
,

*
Departments of Dermatology and Pediatrics,
Herman B. Wells Center for Pediatric Research, and
Howard Hughes Medical Institute, Indiana University School of Medicine, Indianapolis, IN 46202;
§
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206; and
¶
Department of Pharmacology, Ohio State University College of Medicine, Columbus, OH 43210
Recent studies suggest that the lipid mediator platelet-activating factor (PAF) is involved in keratinocyte function and skin inflammation. Indeed, PAF is found in association with inflammatory skin diseases, intradermal injections of PAF induce inflammation, and keratinocytes express functional PAF receptors (PAF-R). One mechanism by which the keratinocyte PAF-R could contribute to epidermal functions and inflammatory states would be through the synthesis of inflammatory regulators, such as PAF, PGs, and cytokines. The ability of the epidermal PAF-R to induce the synthesis of these immunomodulators was tested using a model system created by transduction of the PAF-R-negative human epidermal cell line KB with the PAF-R. Activation of this epidermal PAF-R resulted in arachidonic acid release, and the biosynthesis of PAF and PGE2. In addition, the KB PAF-R triggered increased levels of mRNA and protein for the inducible isozyme of cyclooxygenase (COX-2) as well as IL-6 and IL-8, both of which have been implicated in skin inflammatory processes. Studies with the human keratinocyte-derived epidermal cell line HaCaT revealed that activation of the endogenous PAF-R led to the increased accumulation of COX-2, IL-6, and IL-8 mRNA similar to that seen with the KB PAF-R model system. Finally, treatment of HaCaT keratinocytes with IL-8 resulted in PAF biosynthesis, indicating the existence of a positive feedback loop between IL-8 and PAF in epidermal cells. These studies suggest involvement of PAF and the PAF-R in the epidermal cytokine network.
This article has been cited by other articles:
![]() |
V. O. Melnikova, K. Balasubramanian, G. J. Villares, A. S. Dobroff, M. Zigler, H. Wang, F. Petersson, J. E. Price, A. Schroit, V. G. Prieto, et al. Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis J. Biol. Chem., October 16, 2009; 284(42): 28845 - 28855. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Miura, M. Komai, Y. Adachi, N. Osada, Y. Kameoka, K. Suzuki, and N. Ohno IL-10 Is a Negative Regulatory Factor of CAWS-Vasculitis in CBA/J Mice as Assessed by Comparison with Bruton's Tyrosine Kinase-Deficient CBA/N Mice J. Immunol., September 1, 2009; 183(5): 3417 - 3424. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yao, J. E. Wolverton, Q. Zhang, G. K. Marathe, M. Al-Hassani, R. L. Konger, and J. B. Travers Ultraviolet B Radiation Generated Platelet-Activating Factor Receptor Agonist Formation Involves EGF-R-Mediated Reactive Oxygen Species J. Immunol., March 1, 2009; 182(5): 2842 - 2848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Sreevidya, N. M. Khaskhely, A. Fukunaga, P. Khaskina, and S. E. Ullrich Inhibition of Photocarcinogenesis by Platelet-Activating Factor or Serotonin Receptor Antagonists Cancer Res., May 15, 2008; 68(10): 3978 - 3984. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fukunaga, N. M. Khaskhely, C. S. Sreevidya, S. N. Byrne, and S. E. Ullrich Dermal Dendritic Cells, and Not Langerhans Cells, Play an Essential Role in Inducing an Immune Response J. Immunol., March 1, 2008; 180(5): 3057 - 3064. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rockel, C. Esser, S. Grether-Beck, U. Warskulat, U. Flogel, A. Schwarz, T. Schwarz, D. Yarosh, D. Haussinger, and J. Krutmann The Osmolyte Taurine Protects against Ultraviolet B Radiation-Induced Immunosuppression J. Immunol., September 15, 2007; 179(6): 3604 - 3612. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsumura, S. N. Byrne, D. X. Nghiem, Y. Miyahara, and S. E. Ullrich A Role for Inflammatory Mediators in the Induction of Immunoregulatory B Cells J. Immunol., October 1, 2006; 177(7): 4810 - 4817. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wolf, D. X. Nghiem, J. P. Walterscheid, S. Byrne, Y. Matsumura, Y. Matsumura, C. Bucana, H. N. Ananthaswamy, and S. E. Ullrich Platelet-Activating Factor Is Crucial in Psoralen and Ultraviolet A-Induced Immune Suppression, Inflammation, and Apoptosis Am. J. Pathol., September 1, 2006; 169(3): 795 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cheng, W. Cao, C. Fiocchi, J. Behar, P. Biancani, and K. M. Harnett HCl-induced inflammatory mediators in cat esophageal mucosa and inflammatory mediators in esophageal circular muscle in an in vitro model of esophagitis Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1307 - G1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O. Melnikova, A. A. Mourad-Zeidan, D. C. Lev, and M. Bar-Eli Platelet-activating Factor Mediates MMP-2 Expression and Activation via Phosphorylation of cAMP-response Element-binding Protein and Contributes to Melanoma Metastasis J. Biol. Chem., February 3, 2006; 281(5): 2911 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Marathe, C. Johnson, S. D. Billings, M. D. Southall, Y. Pei, D. Spandau, R. C. Murphy, G. A. Zimmerman, T. M. McIntyre, and J. B. Travers Ultraviolet B Radiation Generates Platelet-activating Factor-like Phospholipids underlying Cutaneous Damage J. Biol. Chem., October 21, 2005; 280(42): 35448 - 35457. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Darst, M. Al-Hassani, T. Li, Q. Yi, J. M. Travers, D. A. Lewis, and J. B. Travers Augmentation of Chemotherapy-Induced Cytokine Production by Expression of the Platelet-Activating Factor Receptor in a Human Epithelial Carcinoma Cell Line J. Immunol., May 15, 2004; 172(10): 6330 - 6335. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Billings, M. D. Southall, T. Li, P. W. Cook, L. Baldridge, W. B. Moores, D. F. Spandau, J. G. Foley, and J. B. Travers Amphiregulin Overexpression Results in Rapidly Growing Keratinocytic Tumors: An In Vivo Xenograft Model of Keratoacanthoma Am. J. Pathol., December 1, 2003; 163(6): 2451 - 2458. [Abstract] [Full Text] |
||||
![]() |
T. Li, M. D. Southall, Q. Yi, Y. Pei, D. Lewis, M. Al-Hassani, D. Spandau, and J. B. Travers The Epidermal Platelet-activating Factor Receptor Augments Chemotherapy-induced Apoptosis in Human Carcinoma Cell Lines J. Biol. Chem., May 2, 2003; 278(19): 16614 - 16621. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Southall, T. Li, L. S. Gharibova, Y. Pei, G. D. Nicol, and J. B. Travers Activation of Epidermal Vanilloid Receptor-1 Induces Release of Proinflammatory Mediators in Human Keratinocytes J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 217 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Moore, T. C. B. McMullen, I. L. Campbell, R. Rohan, Y. Kaji, N. A. Afshari, T. Usui, D. B. Archer, and A. P. Adamis The Inflammatory Milieu Associated with Conjunctivalized Cornea and Its Alteration with IL-1 RA Gene Therapy Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2905 - 2915. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Marques, L. C. Dy, M. D. Southall, Q. Yi, E. Smietana, R. Kapur, M. Marques, J. B. Travers, and D. F. Spandau The Platelet-Activating Factor Receptor Activates the Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Induces Proliferation of Epidermal Cells through an Epidermal Growth Factor-Receptor-Dependent Pathway J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1026 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Walterscheid, S. E. Ullrich, and D. X. Nghiem Platelet-activating Factor, a Molecular Sensor for Cellular Damage, Activates Systemic Immune Suppression J. Exp. Med., January 14, 2002; 195(2): 171 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Southall, J. S. Isenberg, H. Nakshatri, Q. Yi, Y. Pei, D. F. Spandau, and J. B. Travers The Platelet-activating Factor Receptor Protects Epidermal Cells from Tumor Necrosis Factor (TNF) alpha and TNF-related Apoptosis-inducing Ligand-induced Apoptosis through an NF-kappa B-dependent Process J. Biol. Chem., November 30, 2001; 276(49): 45548 - 45554. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lahiri, J. D. Laporte, P. E. Moore, R. A. Panettieri Jr., and S. A. Shore Interleukin-6 family cytokines: signaling and effects in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1225 - L1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Merendino, M. B. Dwinell, N. Varki, L. Eckmann, and M. F. Kagnoff Human intestinal epithelial cells express receptors for platelet-activating factor Am J Physiol Gastrointest Liver Physiol, October 1, 1999; 277(4): G810 - G818. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Dy, Y. Pei, and J. B. Travers Augmentation of Ultraviolet B Radiation-induced Tumor Necrosis Factor Production by the Epidermal Platelet-activating Factor Receptor J. Biol. Chem., September 17, 1999; 274(38): 26917 - 26921. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |